News & Insights
At Accorto Regulatory Solutions we are always keeping a close eye on news in our areas of expertise. Stay up to date with Insights and News from Accorto Regulatory Solutions by signing up for our Newsletter!
News
Understanding the Role of Risk Assessments for FDA Regulatory Submissions: A Key Step in Medical Device Success
November 15, 2024 | Regulatory Insights | Author: Neel Parmar For a successful FDA submission in the US medical device industry, demonstrating the safety and efficacy of your product is [...]
What is FDA’s Standard of Appropriate for the Protection of Public Health?
July 30, 2024 - The following article was developed by Inter Scientific CEO, David Lawson, in collaboration with Accorto's Cheif Science Officer, Dr. Vince Angelico Introduction Those familiar with the Premarket Tobacco Product (PMTA) pathway, [...]
Inter Scientific Completes Move To Expanded State-of-the-Art Laboratory Facility in Liverpool, UK
[EINPresswire.com] LIVERPOOL, UNITED KINGDOM -- 11 JUNE 2024 -- Inter Scientific, a global, industry-leading analytical testing and regulatory compliance firm, announced today that it has completed its move to a custom, 10,000sq-foot state-of-the-art facility [...]
Insights
FDA Granted Regulation of Synthetic Nicotine: What You Need to Know
FDA Granted Regulation of Synthetic Nicotine: What You Need to Know US Government is Redefining "Tobacco Products" On March 15th, 2022 President Biden signed the omnibus spending bill [...]
Don’t Just Win a PMTA Battle, Win the PMTA War
Don't Just Win a PMTA Battle, Win the PMTA War At Accorto Regulatory Solutions, we work with companies who are pushing back on the FDA’s arbitrary and wholesale issuance of Market Denial [...]
New Bill Aims to Regulate Synthetic Nicotine in 2022
New Bill Aims to Regulate Synthetic Nicotine in 2022 On December 15, 2021, Congresswoman Mikie Sherrill from New Jersey announced the introduction of the “Clarifying Authority Over Nicotine Act of 2021”. [...]
